quinacrine and 4-(n-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone

quinacrine has been researched along with 4-(n-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Geromichalos, GD; Harkitis, P; Karamanakos, PN; Konstandi, M; Marselos, M; Pappas, P; Trafalis, DT1

Other Studies

1 other study(ies) available for quinacrine and 4-(n-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone

ArticleYear
Inhibition of rat hepatic CYP2E1 by quinacrine: molecular modeling investigation and effects on 4-(methyl nitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-induced mutagenicity.
    Archives of toxicology, 2009, Volume: 83, Issue:6

    Topics: Adult; Animals; Antimutagenic Agents; Binding Sites; Blotting, Western; Cytochrome P-450 CYP2E1 Inhibitors; Disulfiram; Enzyme Inhibitors; Female; Gene Expression Regulation, Enzymologic; Humans; Isoniazid; Male; Models, Molecular; Mutagens; Nitrosamines; Protein Binding; Quinacrine; Rats; Rats, Wistar; Sister Chromatid Exchange

2009